Sanofi’s Sarclisa receives EU approval for newly diagnosed multiple myeloma
Sanofi's Sarclisa receives EU approval for newly diagnosed multiple myelomaSource: Investing.com
أخبار الاستثمار والأسواق المالية من موقع Investing.com
Sanofi's Sarclisa receives EU approval for newly diagnosed multiple myelomaSource: Investing.com
Meko reports Q2 revenue drop, launches cost reduction programSource: Investing.com

Volkswagen lowers guidance as tariffs hit profit in second quarterSource: Reuters
YIT reports Q2 adjusted EBIT of EUR 10 million, exceeds estimatesSource: Investing.com
Indian alcohol stocks surge on UK trade deal, premium spirits focusSource: Investing.com

Kia Corp takes $570 million hit from US tariffs in second quarterSource: Reuters

CK Hutchison ports deal deadline likely to be extended as US-China tensions weigh, sources saySource: Reuters
Embattled developer Country Garden agrees to key bank demands- BloombergSource: Investing.com

Tech firms to showcase AI innovations in a China under US sanctionsSource: Reuters
Saylor’s Strategy hikes share issue to $2.8 bln amid Bitcoin price boom- BloombergSource: Investing.com